HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Plant-Sourced Food Additive Options For Vitamin D2 Expand To Mushroom Powder

Executive Summary

FDA amends food additive regulations with Oakshire’s petition to use agaricus bisporus mushroom powder, produced using UV light treatment, as a source of vitamin D2 in foods and supplements.

You may also be interested in...

EU Regulatory Round-Up: EFSA Scientific Opinions On Novel Foods, Vitamin K2 Health Claim

Vitamin D mushroom powder, selenium- and chromium-enriched biomass of y. lipolytica and astaxanthin-based pink coloring are novel foods considered by the European Food Safety Authority's Authority’s Panel on Nutrition, Novel Foods and Food Allergens. The NDA also rejects a health claim for NattoPharma’s vitamin K2 food supplement, MenaQ7.

Congress Likely To Legislate Monetary Penalty Authority In FTC Enforcement If SCOTUS Strikes It

White House, Democrat majority in Congress and likely next FTC chair support the agency wielding the authority, says advertising law attorney Holly Melton. Supreme Court, though, likely will rule in pending cases that a strict reading of an FTC regulation doesn’t grant monetary penalty authority.

Despite ‘Almost Nonexistent’ Cough/Cold Season, Perrigo's 2020 Consumer Health Sales Grow 6%

Perrigo is latest consumer health firm to note substantially slower flu rates slammed OTC drug sales during 2020 fourth quarter. Its total cough/cold product sales for the year were off $63m on decreases of $34m in the Americas and $29m in its international markets.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts